Patient No | Sex | Age (years) | Disease duration (years) | Affected joint | Drug | Stage |
1 | F | 55 | 22 | Hip | P, D | IV |
2 | F | 68 | 5 | Hip | P | IV |
3 | F | 57 | 22 | Ankle | P | IV |
4 | F | 49 | 8 | Hip | P, D | III |
5 | F | 63 | 11 | Hip | P | III |
6 | F | 75 | 7 | Knee | P | III |
7 | F | 79 | 5 | Knee | P | III |
8 | F | 69 | 8 | Knee | P | IV |
9 | F | 22 | 7 | Elbow | P | IV |
10 | M | 78 | 7 | Knee | P, D | III |
111-150 | F | 69 | — | Hip | — | — |
121-150 | F | 85 | — | Hip | — | — |
131-150 | F | 72 | — | Hip | — | — |
P = prednisolone; D = disease modifying antirheumatic drugs.
↵1-150 Patients 11–13 are subjects with femoral neck fracture.